Cargando…

Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis

BACKGROUND: Attribute selection represents an important step in the development of discrete-choice experiments (DCEs), but is often poorly reported. In some situations, the number of attributes identified may exceed what one may find possible to pilot in a DCE. Hence, there is a need to gain insight...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiligsmann, Mickael, van Durme, Caroline, Geusens, Piet, Dellaert, Benedict GC, Dirksen, Carmen D, van der Weijden, Trudy, Reginster, Jean-Yves, Boonen, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572758/
https://www.ncbi.nlm.nih.gov/pubmed/23412964
http://dx.doi.org/10.2147/PPA.S38408
_version_ 1782259352272371712
author Hiligsmann, Mickael
van Durme, Caroline
Geusens, Piet
Dellaert, Benedict GC
Dirksen, Carmen D
van der Weijden, Trudy
Reginster, Jean-Yves
Boonen, Annelies
author_facet Hiligsmann, Mickael
van Durme, Caroline
Geusens, Piet
Dellaert, Benedict GC
Dirksen, Carmen D
van der Weijden, Trudy
Reginster, Jean-Yves
Boonen, Annelies
author_sort Hiligsmann, Mickael
collection PubMed
description BACKGROUND: Attribute selection represents an important step in the development of discrete-choice experiments (DCEs), but is often poorly reported. In some situations, the number of attributes identified may exceed what one may find possible to pilot in a DCE. Hence, there is a need to gain insight into methods to select attributes in order to construct the final list of attributes. This study aims to test the feasibility of using the nominal group technique (NGT) to select attributes for DCEs. METHODS: Patient group discussions (4–8 participants) were convened to prioritize a list of 12 potentially important attributes for osteoporosis drug therapy. The NGT consisted of three steps: an individual ranking of the 12 attributes by importance from 1 to 12, a group discussion on each of the attributes, including a group review of the aggregate score of the initial rankings, and a second ranking task of the same attributes. RESULTS: Twenty-six osteoporotic patients participated in five NGT sessions. Most (80%) of the patients changed their ranking after the discussion. However, the average initial and final ranking did not differ markedly. In the final ranking, the most important medication attributes were effectiveness, side effects, and frequency and mode of administration. Some (15%) of the patients did not correctly rank from 1 to 12, and the order of attributes did play a role in the ranking. CONCLUSION: The NGT is feasible for selecting attributes for DCEs. Although in the context of this study, the NGT session had little impact on prioritizing attributes, this approach is rigorous, transparent, and improves the face validity of DCEs. Additional research in other contexts (different decisional problems or different diseases) is needed to determine the added value of the NGT session, to assess the optimal ranking/rating method with control of ordering effects, and to compare the attributes selected with the different approaches.
format Online
Article
Text
id pubmed-3572758
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-35727582013-02-14 Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis Hiligsmann, Mickael van Durme, Caroline Geusens, Piet Dellaert, Benedict GC Dirksen, Carmen D van der Weijden, Trudy Reginster, Jean-Yves Boonen, Annelies Patient Prefer Adherence Original Research BACKGROUND: Attribute selection represents an important step in the development of discrete-choice experiments (DCEs), but is often poorly reported. In some situations, the number of attributes identified may exceed what one may find possible to pilot in a DCE. Hence, there is a need to gain insight into methods to select attributes in order to construct the final list of attributes. This study aims to test the feasibility of using the nominal group technique (NGT) to select attributes for DCEs. METHODS: Patient group discussions (4–8 participants) were convened to prioritize a list of 12 potentially important attributes for osteoporosis drug therapy. The NGT consisted of three steps: an individual ranking of the 12 attributes by importance from 1 to 12, a group discussion on each of the attributes, including a group review of the aggregate score of the initial rankings, and a second ranking task of the same attributes. RESULTS: Twenty-six osteoporotic patients participated in five NGT sessions. Most (80%) of the patients changed their ranking after the discussion. However, the average initial and final ranking did not differ markedly. In the final ranking, the most important medication attributes were effectiveness, side effects, and frequency and mode of administration. Some (15%) of the patients did not correctly rank from 1 to 12, and the order of attributes did play a role in the ranking. CONCLUSION: The NGT is feasible for selecting attributes for DCEs. Although in the context of this study, the NGT session had little impact on prioritizing attributes, this approach is rigorous, transparent, and improves the face validity of DCEs. Additional research in other contexts (different decisional problems or different diseases) is needed to determine the added value of the NGT session, to assess the optimal ranking/rating method with control of ordering effects, and to compare the attributes selected with the different approaches. Dove Medical Press 2013-02-07 /pmc/articles/PMC3572758/ /pubmed/23412964 http://dx.doi.org/10.2147/PPA.S38408 Text en © 2013 Hiligsmann et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Hiligsmann, Mickael
van Durme, Caroline
Geusens, Piet
Dellaert, Benedict GC
Dirksen, Carmen D
van der Weijden, Trudy
Reginster, Jean-Yves
Boonen, Annelies
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
title Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
title_full Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
title_fullStr Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
title_full_unstemmed Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
title_short Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
title_sort nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572758/
https://www.ncbi.nlm.nih.gov/pubmed/23412964
http://dx.doi.org/10.2147/PPA.S38408
work_keys_str_mv AT hiligsmannmickael nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT vandurmecaroline nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT geusenspiet nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT dellaertbenedictgc nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT dirksencarmend nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT vanderweijdentrudy nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT reginsterjeanyves nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis
AT boonenannelies nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis